ArticleJournal of hematology & oncology2015

Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy.

Heather H Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.